Published October 23, 2025
Cellebrite: Product History & Inseyets Platform
inpractise.com/articles/cellebrite-product-history-and-inseyets-platform
Executive Bio
Former Executive at Cellebrite
Summary
Subscribe to access hundreds of interviews and primary research
Or contact sales for full access
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
This is a snippet of the transcript.to get full access.
How does that impact your ability to raise prices?
The second strategy involved changing the business model. Instead of selling a license for one UFED, the model shifted to charging based on usage, value, or volume, depending on the product. For example, Premium was initially sold with a package of unlocks. You buy a package of a certain number of unlocks that you can use. So, the more you use, the more you pay.
This is a snippet of the transcript.to get full access.
How does that impact your ability to raise prices?
Pathfinder and Guardian have components based on users and data volume. The more users you have, the more you pay. The more investigations you run, the more data you store, the more you pay. This happens without raising the unit cost or price per se. Your price list stays the same, but you provide more value, and the customer pays more due to the increased value.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content

Cellebrite: European Market Procurement
Former Sales Executive at Cellebrite

Cellebrite: Grayshift Mobile Forensics
Former Sales Executive at Grayshift

Cellebrite: Pathfinder Product Origins
Former Executive at Cellebrite

Vista Equity: Due Diligence & Sales Alignment
Former Value Creation Director at Vista Equity
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.